The Mechanism of Action of KBT-3022, a New Antiplatelet Agent

By Matsuo K.   Yokota K.   Yamashita A.   Oda M.  

General Pharmacology, Vol. 28, Iss. 2, 1997-02 ,pp. : 229-235

Elsevier

Access to resources Recommend Favorite

Antithrombotic effects in a rat model of aspirin-insensitive arterial thrombosis of desethyl KBT-3022, the main active metabolite of a new antiplatelet agent, KBT-3022

By Shimazawa M.   Takiguchi Y.   Umemura K.   Kondo K.   Nakashima M.  

European Journal of Pharmacology, Vol. 328, Iss. 2, 1997-09 ,pp. : 183-189

Elsevier

Access to resources Recommend Favorite

The In Vitro and In Vivo Inhibitory Effect of Dehydroaltenusin: A Specific Inhibitor of Mammalian DNA Polymerase 

By  

Current Bioactive Compounds, Vol. 2, Iss. 1, 2006-03 ,pp. : 3-11

Bentham Science Publishers

Access to resources Recommend Favorite

Stereospecific in vitro and in vivo effects of the new sinus node inhibitor (+)-S 16257

By Thollon C.   Bidouard J.-P.   Cambarrat C.   Lesage L.   Reure H.   Delescluse I.   Vian J.   Peglion J.-L.   Vilaine J.-P.  

European Journal of Pharmacology, Vol. 339, Iss. 1, 1997-11 ,pp. : 43-51

Elsevier

Access to resources Recommend Favorite

Gastrointestinal tolerability of nimesulide, a selective cyclooxygenase-2 inhibitor, in experimental animals and man

By Sigthorsson Gudmundur   Thjodleifsson Bjarni   Mahmud Taher   Bjarnason Ingvar  

Inflammopharmacology, Vol. 8, Iss. 2, 2000-06 ,pp. : 175-187

VSP

Access to resources Recommend Favorite